000 01428 a2200445 4500
005 20250518031559.0
264 0 _c20190717
008 201907s 0 0 eng d
022 _a2314-6141
024 7 _a10.1155/2019/2075968
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLiu, Zhong-Yu
245 0 0 _aLess Vertebral Bone Mass after Treatment with Macitentan in Mice: A Pilot Study.
_h[electronic resource]
260 _bBioMed research international
_c2019
300 _a2075968 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aBone Density
_xdrug effects
650 0 4 _aCancellous Bone
_xdiagnostic imaging
650 0 4 _aEndothelin-1
_xmetabolism
650 0 4 _aHypertension
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aOsteoblasts
_xmetabolism
650 0 4 _aPilot Projects
650 0 4 _aPyrimidines
_xadverse effects
650 0 4 _aSpine
_xdiagnostic imaging
650 0 4 _aSulfonamides
_xadverse effects
700 1 _aAu, Man-Ting
700 1 _aHe, Tian-Wei
700 1 _aYang, Bu
700 1 _aLiu, Bin
700 1 _aZhang, Liang-Ming
700 1 _aLuo, Chun-Xiao
700 1 _aRong, Li-Min
700 1 _aWen, Chun-Yi
773 0 _tBioMed research international
_gvol. 2019
_gp. 2075968
856 4 0 _uhttps://doi.org/10.1155/2019/2075968
_zAvailable from publisher's website
999 _c29516774
_d29516774